Related Experiment Videos
Disseminated intravascular coagulation: pathogenesis, diagnosis, and therapy
The Journal of Emergency Medicine
|July 1, 1987
Summary
Disseminated intravascular coagulation (DIC) is a critical condition secondary to other diseases, causing bleeding and organ damage. Early diagnosis and treatment of the underlying cause are vital for managing this complex coagulopathy.
Area of Science:
- Hematology
- Pathophysiology
- Internal Medicine
Background:
- Disseminated intravascular coagulation (DIC) is a life-threatening condition characterized by abnormal activation of coagulation.
- It arises as a secondary complication of various underlying pathologies, leading to both thrombosis and hemorrhage.
- The process involves consumption of clotting factors and platelets, fibrin deposition, and activation of fibrinolysis.
Purpose of the Study:
- To review the pathogenesis, diagnosis, and treatment of DIC.
- To highlight the importance of identifying predisposing conditions and utilizing laboratory tests for diagnosis.
- To discuss current and experimental therapeutic strategies.
Main Methods:
- Review of existing literature on DIC.
- Analysis of diagnostic criteria and laboratory findings.
- Evaluation of therapeutic approaches, including supportive care and anticoagulation.
Main Results:
- DIC is characterized by a complex interplay of thrombotic and hemorrhagic manifestations.
- Diagnosis relies on clinical suspicion of underlying diseases and specific laboratory markers.
- Treatment involves addressing the primary disease and managing bleeding/thrombosis with replacement therapy and potentially heparin.
Conclusions:
- DIC is a secondary complication requiring prompt recognition and management of the underlying cause.
- Effective diagnosis integrates clinical context with laboratory data.
- Therapeutic strategies aim to restore hemostasis and prevent further complications.
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
205
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
205
Venous Thrombosis I: Introduction
187
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
187
Anticoagulant Drugs: Low-Molecular-Weight Heparins
1.4K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
1.4K
Extrinsic and Intrinsic Pathways of Hemostasis
11.4K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
11.4K
Disorders of Hemostasis
1.8K
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
1.8K
Coagulation
9.4K
The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
9.4K